Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
Latest Information Update: 08 Dec 2017
At a glance
- Drugs CAR-T cell therapies (Primary)
- Indications B-cell leukaemia; B-cell lymphoma
- Focus Adverse reactions
- Sponsors Shenzhen Innovation Immunotechnology
- 08 Dec 2017 New trial record